24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Matthew Gubens is a board-certified medical oncologist based in San Francisco, California. He graduated from the Stanford University School of Medicine and did his residency in internal medicine at the UCSF. He also did a fellowship in medical oncology at the Stanford University. He is specialized in the treatment of cancer affecting the larynx, lungs, and mesothelioma. With about two decades of clinical experience, Dr. Gubens is affiliated with the UCSF Medical Center and has also contributed to several research publications.
Stanford University
Medical School
UCSF
Residency
Stanford University
Fellowship
American Board of Internal Medicine - Oncology
UCSF Medical Center
Languages: English/Spanish
(415) 353-1037
505 Parnassus Ave
San Francisco, California 94143 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.
Sanlorenzo, M.,Vujic, I.,Daud, A.,Algazi, A.,Gubens, M.,Luna, S. A.,Lin, K.,Quaglino, P.,Rappersberger, K.,Ortiz-Urda, S.; JAMA Dermatol. 2015 Jul 30.
See more >>
A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors.
Smith, D. C.,Eisenberg, P. D.,Manikhas, G.,Chugh, R.,Gubens, M. A.,Stagg, R. J.,Kapoun, A. M.,Xu, L.,Dupont, J.,Sikic, B.; Clin. Cancer Res.. 2014 Oct 18.
See more >>
Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.
Woodard, G. A.,Gubens, M. A.,Jahan, T. M.,Jones, K. D.,Kukreja, J.,Theodore, P. R.,Cardozo, S.,Jew, G.,Clary-Macy, C.,Jablons, D. M.,Mann, M. J.; Clin Lung Cancer. 2014 Sep 27.
See more >>